A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation therapy oncology group 0320

International Journal of Radiation Oncology Biology Physics

Volumn 85, Issue 5, 2013, Pages 1312-1318

  Sperduto, Paul W ^a   Wang, Meihua ^b   Robins, H Ian ^c   Schell, Michael C ^d   Werner Wasik, Maria ^e   Komaki, Ritsuko ^f   Souhami, Luis ^g   Buyyounouski, Mark K ^h   Khuntia, Deepak ⁱ   Demas, William ^j   Shah, Sunjay A ^k   Nedzi, Lucien A ^l   Perry, Gad ^m   Suh, John H ⁿ   Mehta, Minesh P ^o  

^a Metro MN CCOP   (United States)

^b RTOG Statistical Center   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h FOX CHASE CANCER CENTER   (United States)

ⁱ University of Wisconsin Health   (United States)

^j AKRON CITY HOSPITAL   (United States)

^k CHRISTIANA CARE HEALTH SYSTEM   (United States)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^m OTTAWA REGIONAL CANCER CENTRE   (Canada)

ⁿ LERNER RESEARCH INSTITUTE   (United States)

^o NORTHWESTERN MEMORIAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEMS; MEDIAN SURVIVAL TIME; METHODS AND MATERIALS; NON SMALL CELL LUNG CANCER; RADIATION THERAPY ONCOLOGY GROUPS; STEREOTACTIC RADIOSURGERY; WHOLE BRAIN RADIATION THERAPIES;

DISEASES; ONCOLOGY; RADIOTHERAPY; TOXICITY;

BRAIN;

ERLOTINIB; STEROID; TEMOZOLOMIDE;

ADULT; ARTICLE; BRAIN METASTASIS; BRAIN NECROSIS; BRAIN RADIATION; CANCER COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DEPENDENCE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEREOTACTIC RADIOSURGERY; SURVIVAL TIME; TREATMENT DURATION; WHOLE BRAIN RADIATION THERAPY;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; DACARBAZINE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RADIOSURGERY; RADIOTHERAPY DOSAGE;

EID: 84875239644     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.11.042     Document Type: Article

References (15)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. L.J. Schouten, J. Rutten, and H.A. Huveneers Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, lung and melanoma Cancer 94 2002 2698 2705
3. J.B. Posner Neurologic Complications of Cancer 1995 FA Davies Philadelphia
4. P.W. Sperduto, N. Kased, and D. Roberge Summary report on the Graded Prognostic Assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases J Clin Oncol 30 2012 419 425
5. D.W. Andrews, C.B. Scott, and P.W. Sperduto Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Lancet 363 2004 1665 1672
6. Dardoufas C, Miliadou A, Skarleas C, et al. Concomitant temozolomide (TMZ) and radiotherapy (RT) followed by adjuvant treatment with temozolomide in patients with brain metastases from solid tumors. American Society of Clinical Oncology 37th Annual Meeting, San Francisco, CA, May 12-15, 2002. Proceedings ASCO 2001;20:75b (Abstract 2048).
7. D. Antonadou, M. Paraskevaidis, and G. Sarris Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases J Clin Oncol 20 2002 3644 3650
8. Verger E, Gil M, Yaya R, et al. Concomitant temozolomide (TMZ) and whole brain radiotherapy (WBRT) in patients with brain metastases (BM): randomized multicentric phase II study. American Society of Clinical Oncology 39th Annual Meeting, Chicago, II, May 31-June 3, 2003. Proceedings ASCO 2003;22:101 (Abstract 404).
9. D. Chua, M. Krzakowski, and C. Chouaid Whole brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small cell lung cancer: a randomized, open-label phase II study Clin Lung Cancer 11 2010 176 181
10. Gatzemeier U, Pluzanska A, Szczesnz A, et al. Results of a phase III trial of erlotinib (OSI 774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC). Proceedings ASCO 2004;22:14S (Abstract 7010).
11. Herbst RS, Prager D, Hermann R, et al. A phase III trial of erlotinib HCl (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC). Proceedings ASCO 2004;22:14S (Abstract 7011).
12. M. Zelen The randomization and stratification of patients to clinical trials J Chronic Dis 27 1974 365 375
13. R.J. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Statist 16 1988 1141 1154
14. J.M. McDonald, C.E. Pelloski, and A. Ledoux Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lung Clin Cancer Res 14 2008 7832 7837
15. M. Sun, C. Behrens, and L. Feng HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors Clin Cancer Res 15 2009 4829 4837